Search

everythinglearnresearchcommunity

for

Search:↓

Too much AKR1C3 enzyme causes resistance to finasteride by increasing testosterone.

Cyproterone acetate effectively reduced hair growth in hirsute patients by lowering androgen levels and altering androgen metabolism.

Finasteride increases P-glycoprotein activity in the liver and kidney.

Antiretrovirals can affect finasteride's effectiveness, so dose adjustments may be needed for men on HIV treatment.

Melatonin stops melanin production after tyrosinase action, with cyclic GMP mimicking this effect.

Cilostazol may help hair grow and could be a new treatment for hair loss.

Cyproterone acetate effectively treats sexual disorders by reducing sexual functions and is generally well-tolerated.

Compound 4 is a promising treatment for hair loss with low toxicity.

Finasteride increases CD8+ T cells in BPH tissues.

PM-9, like finasteride, may help treat certain diseases by blocking a key enzyme.

P-3074 effectively blocks scalp DHT better than oral finasteride.

Scientists found a new gene in a bacterium that can modify an immunosuppressant drug, potentially helping to treat hair loss.

In 2002, various drugs caused serious side effects, including vitamin B12 deficiency, heart issues, blindness, hypersexuality, allergic reactions, blood clotting problems, pupil dilation, capillary leak syndrome, muscle breakdown, hepatitis, skin reactions, and lupus.

Cinnamomi cortex may help treat prostate enlargement by reducing related proteins.

New pyrazole-based inhibitors show promise for treating metabolic diseases and other conditions.

Cilostazol helps hair grow by making hair root cells grow faster and changing growth factor levels.

Finasteride may affect male fertility by interfering with specific sperm signaling.

MK-0773 is a moderate inhibitor of the SRD5A2 enzyme.

The medication combination did not affect glucose tolerance but increased some cholesterol levels due to its estrogen component.

Steroidogenesis inhibitors change but don't stop androgen production in prostate cancer.

Finasteride blocks progesterone production in specific tumor cells, potentially causing side effects.

PDE5 inhibitors cause earlier adverse events in BPH treatment, requiring careful monitoring.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Some people have a genetic variation that makes them less effective at breaking down drugs.

Ticagrelor works better than clopidogrel in reducing platelet activity in elderly patients with acute coronary syndrome.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

CB-03-04 shows promise as a treatment for prostate issues due to its strong anti-androgen effects.